Lanean...
Ribociclib-Induced Pneumonitis: A Case Report
BACKGROUND: Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have been a significant breakthrough in the management of hormone receptor-positive, HER2-negative metastatic breast cancer based on the results of several large phase III randomized trials. The most common reported toxicity is myelosuppre...
Gorde:
| Argitaratua izan da: | Breast Care (Basel) |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
S. Karger AG
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248782/ https://ncbi.nlm.nih.gov/pubmed/34248473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507647 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|